Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023. Pipeline ...

Like thousands of women who are targeted hourly on social media with ads selling Mounjaro, or Ozempic, Aisleyne believed what she was buying was safe. This is an issue for many people as fake ...

Mounjaro (tirzepatide) is a prescription drug used to help manage blood sugar levels in adults with type 2 diabetes. Mounjaro comes as an injection that’s given under your skin. This medication ...

Karachi's weather is expected to remain dry and cool over the next 24 hours, with light fog forecasted for Wednesday morning. The Pakistan Meteorological Department (PMD) recorded a minimum ...

Eli Lilly markets its tirzepatide medicines, Mounjaro for T2D and Zepbound for obesity, which competes with NVO’s Ozempic and Wegovy. The fall in LLY’s stock price is likely because investors ...

Jeff Horing’s Insight Partners is to New York venture capital what Andreessen Horowitz and Sequoia are to Silicon Valley. And it’s a status that has been cemented with Insight’s latest ...

Insight Partners, a New York-based venture capital and private equity firm, has raised $12.5 billion for its 13th flagship fund — a large sum that was reduced from an even larger target.